Skip to main content

GOLDMAN SACHS GROUP INC

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 886982 NEW YORK, NY

Position in SNDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$128,127,252
+$11,402,309 QoQ
Shares Held
5,861,265
+17.3% QoQ
Ownership
6.56%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SNDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. SNDX ranks #26 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SNDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $128,127,252 5,861,265
2026-03-31 $116,724,943 4,996,787
2025-12-31 $119,659,828 5,695,375
2025-09-30 $84,408,786 5,486,434
2025-06-30 $54,290,730 5,797,195
2025-03-31 $48,176,130 3,921,541
2024-12-31 $78,666,098 5,950,537
2024-09-30 $31,032,000 1,612,052
2024-06-30 $29,645,565 1,444,012
2024-03-31 $31,179,736 1,310,073
2023-12-31 $27,032,985 1,250,948
2023-09-30 $18,407,699 1,267,748
2023-06-30 $15,621,838 746,385
2023-03-31 $10,365,125 490,773
2022-12-31 $11,153,283 438,243
2022-09-30 $13,650,985 568,081
2022-06-30 $10,509,637 546,239
2022-03-31 $7,095,610 408,263
2021-12-31 $7,960,538 363,661
2021-09-30 $6,117,262 320,108
2021-06-30 $18,488,106 1,076,768
2021-03-31 $12,602,207 563,605
2020-12-31 $12,330,612 554,434
2020-09-30 $3,719,076 251,970
2020-06-30 $6,483,186 437,462
2020-03-31 $172,108 15,689